Chemoinformaics analysis of 4,8-DIMETHOXY-1-(2-METHOXYETHYL)-BETA-CARBOLINE
| Molecular Weight | 286.331 | nRot | 5 |
| Heavy Atom Molecular Weight | 268.187 | nRig | 15 |
| Exact Molecular Weight | 286.132 | nRing | 3 |
| Solubility: LogS | -2.309 | nHRing | 2 |
| Solubility: LogP | 2.169 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 15 |
| nHA | 4 | APOL | 43.3283 |
| nHD | 1 | BPOL | 24.9757 |
| QED | 0.783 |
| Synth | 2.512 |
| Natural Product Likeliness | 0.525 |
| NR-PPAR-gamma | 0.846 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.036 |
| Pgp-sub | 0.946 |
| HIA | 0.006 |
| CACO-2 | -4.839 |
| MDCK | 0.0000157 |
| BBB | 0.712 |
| PPB | 0.830428 |
| VDSS | 1.029 |
| FU | 0.140255 |
| CYP1A2-inh | 0.986 |
| CYP1A2-sub | 0.982 |
| CYP2c19-inh | 0.815 |
| CYP2c19-sub | 0.808 |
| CYP2c9-inh | 0.553 |
| CYP2c9-sub | 0.818 |
| CYP2d6-inh | 0.695 |
| CYP2d6-sub | 0.879 |
| CYP3a4-inh | 0.739 |
| CYP3a4-sub | 0.883 |
| CL | 6.47 |
| T12 | 0.644 |
| hERG | 0.025 |
| Ames | 0.558 |
| ROA | 0.963 |
| SkinSen | 0.407 |
| Carcinogencity | 0.728 |
| EI | 0.382 |
| Respiratory | 0.977 |
| NR-Aromatase | 0.882 |
| Antiviral | Yes |
| Prediction | 0.779061 |